Krystal Biotech, Inc. KRYS Accrued legal settlement
Accrued legal settlement at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept krys:IncreaseDecreaseAccruedLegalSettlementAndInProcessResearchAndDevelopment.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s accrued legal settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s accrued legal settlement?
- Krystal Biotech, Inc. (KRYS) reported accrued legal settlement of $0 in Q1 2026.
- How has Krystal Biotech, Inc.'s accrued legal settlement changed year-over-year?
- Krystal Biotech, Inc.'s accrued legal settlement increased by 100.0% year-over-year, from -$31.25M to $0.
- What does accrued legal settlement mean?
- The change in the company's liability for legal settlements.
- How do you interpret accrued legal settlement?
- A decrease indicates a cash outflow for legal settlements, while an increase suggests the accrual of new legal contingencies.
- How does accrued legal settlement compare across companies?
- Specific to companies facing litigation; generally viewed as a non-recurring or risk-related item.